Karius to present studies at ASM Microbe 2019 demonstrating clinical utility of the Karius Test, including ability to accurately detect pathogens in cases of endocarditis and immunocompromised patients
Read More —>
Read More
Mammoth Biosciences and Pacific 8 Ventures Keynote Speakers at Bio Medtex Conference in November 2018
/
Mammoth Biosciences and Pacific 8 Ventures Keynote Speakers at Bio Medtex Conference in November 2018
Read More
Congratulations to co-founder at BillionToOne for being recognized in the Forbes Top 30 under 30 of 2019→
/
Working the lab of Nobel laureate Andrew Fire, Sukrit Silas discovered how bacteria use CRISPR, which is part of their immune system, to learn to attack viruses that are made of the genetic material RNA. His company, BillionToOne, has raised $2.5 million and is developing diagnostics for beta thalassemia and Down syndrome.
Read More —>
Read More
Karius Announces Launch of Quantitative, Broad-Based Infectious Disease Diagnostic Test Using Microbial Cell-Free DNA→
/
Karius, the leading U.S. infectious disease genomics company, announced today that the new version of its proprietary KariusTM Test can now quantify the abundance of pathogens detected. The test uses next-generation sequencing of microbial cell-free DNA (cfDNA) to identify over 1,000 pathogens from a single blood sample. Results are typically delivered the next day.
Reade More —>
Read MoreInsurtech Startup Wellthie Selects Teladoc for Telehealth and Consumer Engagement Solution→
/
Wellthie, an insurance technology company offering sales technology to producer and carrier partners that wish to modernize their distribution process, has just announced its selection of the HealthiestYou telehealth and consumer engagement product by Teladoc, the world’s largest provider of virtual care delivery services.
Read More —>
Read More